Amiodaronem indukované postižení plic u pacienta s fibrilací síní

HUDEC, Martin, Petra VYSOČANOVÁ, Vojtěch BRÁZDIL, Martin POLOCZEK, Martin HETMER, Jiřina LITTLE, Martina DOUBKOVÁ a Petr KALA. Amiodaronem indukované postižení plic u pacienta s fibrilací síní. Vnitřní lékařství. Praha: Česká lékařská společnost J. E. Purkyně, 2021, roč. 67, č. 7, s. "E18"-"E23", 6 s. ISSN 0042-773X. Dostupné z: https://dx.doi.org/10.36290/VNL.2021.116.

Základní údaje

Originální název

Amiodaronem indukované postižení plic u pacienta s fibrilací síní

Název anglicky

Amiodarone induced pulmonary toxicity

Autoři

HUDEC, Martin (203 Česká republika, garant, domácí), Petra VYSOČANOVÁ (203 Česká republika, domácí), Vojtěch BRÁZDIL (203 Česká republika, domácí), Martin POLOCZEK (203 Česká republika, domácí), Martin HETMER (203 Česká republika), Jiřina LITTLE (203 Česká republika), Martina DOUBKOVÁ (203 Česká republika, domácí) a Petr KALA (203 Česká republika, domácí)

Vydání

Vnitřní lékařství, Praha, Česká lékařská společnost J. E. Purkyně, 2021, 0042-773X

---

Další údaje

Jazyk

čeština

Typ výsledku

Článek v odborném periodiku

Obor

30203 Respiratory systems

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Kód RIV

RIV/00216224:14110/21:00128163

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.36290/VNL.2021.116

Klíčová slova česky

AIPT; Amiodarone; Amiodarone induced pulmonary toxicity; Amiodarone lung

Klíčová slova anglicky

AIPT; Amiodarone; Amiodarone induced pulmonary toxicity; Amiodarone lung

Štítky

rivok

Příznaky

Recenzováno

---

Anotace

V originále

Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias. Many adverse effects, more or less serious, are associated with its administration. Amiodaron-induced pulmonary toxicity (AIPT) is quite rare but represents one of the most severe adverse effects with high mortality. We present an 80 years old patient, who used amidorane due to paroxysmal atrial fibrillation for several years. Within 3 months, he was repeatedly hospitalized for a bilateral pneumonia. Eventually, AIPT was diagnosed. Early diagnosis, proper therapy of AIPT and changed antiarrhythmic therapy has significantly improved the clinical status of our patient. In this case we demonstrate typical clinical presentations of AIPT as well as the most common diagnostic procedures and recommended treatment methods. Finally, some other commonly used therapeutical options for supraventricular arrhythmias are mentioned. Future options are outlined. © 2021, SOLEN s.r.o.. All rights reserved.

Anglicky

Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias. Many adverse effects, more or less serious, are associated with its administration. Amiodaron-induced pulmonary toxicity (AIPT) is quite rare but represents one of the most severe adverse effects with high mortality. We present an 80 years old patient, who used amidorane due to paroxysmal atrial fibrillation for several years. Within 3 months, he was repeatedly hospitalized for a bilateral pneumonia. Eventually, AIPT was diagnosed. Early diagnosis, proper therapy of AIPT and changed antiarrhythmic therapy has significantly improved the clinical status of our patient. In this case we demonstrate typical clinical presentations of AIPT as well as the most common diagnostic procedures and recommended treatment methods. Finally, some other commonly used therapeutical options for supraventricular arrhythmias are mentioned. Future options are outlined. © 2021, SOLEN s.r.o.. All rights reserved.